Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 11, 2008, Pages 627-633

  Iori, Elisabetta ^a   Millioni, Renato ^a   Puricelli, Lucia ^a   Arrigoni, Giorgio ^b,d   Lenzini, Livia ^a   Trevisan, Roberto ^c   James, Peter ^d   Rossi, Gian Paolo ^a   Pinna, Lorenzo A ^b   Tessari, Paolo ^a  

^a Department of Clinical and Experimental Medicine ^*  (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d Protein Technology   (Sweden)

Author keywords

Human skin fibroblast; Two dimensional electrophoresis; Type 1 diabetic nephropathy

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE; GLYCOLYTIC ENZYME; HEXOKINASE; INSULIN; PHOSPHOGLUCOMUTASE; PYRUVATE KINASE; RNA; TRIOSEPHOSPHATE ISOMERASE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY INJURY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; RNA ANALYSIS; SKIN BIOPSY; SKIN FIBROBLAST; SPECTROPHOTOMETRY; TRANSCRIPTOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

ADULT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FIBROBLASTS; GLYCOLYSIS; HUMANS; MALE; MICROARRAY ANALYSIS; PYRUVATE KINASE;

EID: 55249086572     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.08.012     Document Type: Article

References (38)

1. Krolewski M., Eggers P.W., and Warram J.H. Magnitude of end-stage renal disease in IDDM: a 35-year follow-up study. Kidney Int. 50 (1996) 2041-2046
2. Yip J., Mattock M.B., Morocutti A., Sethi M., Trevisan R., and Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342 (1993) 883-887
3. Groop P.H., Forsblom C., and Thomas M.C. Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat. Clin. Pract. Endocrinol. Metab. 1 (2005) 100-110
4. De Cosmo S., Argiolas A., Miscio G., Thomas S., Piras G.P., Trevisan R., Perin P.C., Bacci S., Zucaro L., Margaglione M., Frittitta L., Pizzuti A., Tassi V., Viberti G.C., and Trischitta V. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes 49 (2000) 521-524
5. Iori E., Marescotti M.C., Vedovato M., Ceolotto G., Avogaro A., Tiengo A., Del Prato S., and Trevisan R. In situ protein kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy. Diabetologia 46 (2003) 524-530
6. LaPointe M.S., and Batlle D. Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy. Am. J. Kidney Dis. 38 (2001) 646-648
7. Simonson M.S. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int. 71 (2007) 846-854
8. Pessin J.E., and Okada S. Insulin and EGF receptors integrate the Ras and Rap signaling pathways. Endocr. J. 46 (1999) S11-S16
9. Podestà F., Meregalli G., Ghelardi R., Del Giudice R., Asnaghi V., Maestroni A., and Zerbini G. Low Ca(2+) pump activity in diabetic nephropathy. Am. J. Kidney Dis. 38 (2001) 465-472
10. Shackel N.A., Seth D., Haber P.S., Gorrell M.D., and McCaughan G.W. The hepatic transcriptome in human liver disease. Comp. Hepatol. 5 (2006) 6
11. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., and Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 4 (2002) 323-333
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
13. Lenzini L., Seccia T.M., Alighieri E., Belloni A.S., Bernante P., Giuliani L., Nussdorfer G.G., Pessina A.C., and Rossi G.P. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50 (2007) 1106-1113
14. Puricelli L., Iori E., Millioni R., Arrigoni G., James P., Vedovato M., and Tessari P. Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J. Clin. Endocrinol. Metab. 91 (2006) 3507-3514
15. Gutmann I., and Bernt E. Pyruvate kinase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis 2 (1974), Verlag Chemie Weinheim, Academic Press, Inc., New York and London 774-777
16. Meyer C., Tolias A., Platanisiotis D., Stumvoll M., Vlachos L., and Mitrakou A. Increased renal glucose metabolism in Type 1 diabetes mellitus. Diabet. Med. 22 (2005) 453-459
17. Beck-Nielsen H. Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase. J. Basic Clin. Physiol. Pharmacol. 9 (1998) 255-279
18. Ristow M., Vorgerd M., Möhlig M., Schatz H., and Pfeiffer A. Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. J. Clin. Invest. 100 (1997) 2833-2841
19. Leyva F., Wingrove C.S., Godsland I.F., and Stevenson J.C. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism 47 (1998) 657-662
20. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1-E8
21. Holness M.J., and Sugden M.C. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem. Soc. Trans. 31 (2003) 1143-1151
22. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., and Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8466-8471
23. Belfiore F., Rabuazzo A.M., Napoli E., Borzi V., and Lo Vecchio L. Enzymes of glucose metabolism and of the citrate cleavage pathway in adipose tissue of normal and diabetic subjects. Diabetes 24 (1975) 865-873
24. Lupi R., Marselli L., Dionisi S., Del Guerra S., Boggi U., Del Chiaro M., Lencioni C., Bugliani M., Mosca F., Di Mario U., Del Prato S., Dotta F., and Marchetti P. Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients. Diabetes Metab. Res. Rev. 20 (2004) 246-251
25. Kondoh Y., Kawase M., Kawakami Y., and Ohmori S. Concentrations of d-lactate and its related metabolic intermediates in liver, blood, and muscle of diabetic and starved rats. Res. Exp. Med. (Berl) 192 (1992) 407-414
26. Diamant Y.Z., and Shafrir E. Placental enzymes of glycolysis, gluconeogenesis and lipogenesis in the diabetic rat and in starvation. Comparison with maternal and foetal liver. Diabetologia 15 (1978) 481-485
27. Rossi I., Sanchez-Arias J.A., and Feliu J.E. Effect of streptozotocin diabetes on the glycolytic flux and on fructose 2,6-bisphosphate levels in isolated rat enterocytes. Metabolism 39 (1990) 882-885
28. Parks W.C., and Drake R.L. Insulin mediates the stimulation of pyruvate kinase by a dual mechanism. Biochem. J. 208 (1982) 333-337
29. Asai Y., Yamada K., Watanabe T., Keng V.W., and Noguchi T. Insulin stimulates expression of the pyruvate kinase M gene in 3T3-L1 adipocytes. Biosci. Biotechnol. Biochem. 67 (2003) 1272-1277
30. Pessin J.E., and Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 106 (2000) 165-169
31. Cusi K., Maezono K., Osman A., Pendergrass M., Patti M.E., Pratipanawatr T., DeFronzo R.A., Kahn C.R., and Mandarino L.J. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signalling in human muscle. J. Clin. Invest. 105 (2000) 311-320
32. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengeller Z., Szabo C., and Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112 (2003) 1049-1057
33. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
34. Lehninger A.L. Biochemistry (1970), Worth Publisher Inc., New York, USA 321
35. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell. Mol. Life Sci. 58 (2001) 902-920
36. Yan L., Ge H., Li H., Lieber S.C., Natividad F., Resuello R.R., Kim S.J., Akeju S., Sun A., Loo K., Peppas A.P., Rossi F., Lewandowski E.D., Thomas A.P., Vatner S.F., and Vatner D.E. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J. Mol. Cell. Cardiol. 37 (2004) 921-929
37. Akisawa N., Maeda T., Iwasaki S., and Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J. Hepatology 26 (1997) 845-851
38. Orth T., Kellner R., Diekmann O., Faus J., Meyer zum Büschenfelde K.H., and Mayet W.J. Identification and characterization of autoantibodies against catalase and alphaenolase in patients with primary sclerosing cholangitis. Clin. Exp. Immunol. 112 (1998) 507-515